Aytu BioPharma Inc (AYTU)
2.80
+0.08
(+3.13%)
USD |
NASDAQ |
Apr 24, 16:00
Aytu BioPharma Cash from Operations (TTM): 6.113M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.113M |
| September 30, 2023 | 3.808M |
| June 30, 2023 | -5.129M |
| March 31, 2023 | -21.59M |
| December 31, 2022 | -27.80M |
| September 30, 2022 | -34.18M |
| June 30, 2022 | -28.82M |
| March 31, 2022 | -28.00M |
| December 31, 2021 | -27.67M |
| September 30, 2021 | -21.77M |
| June 30, 2021 | -25.96M |
| March 31, 2021 | -27.45M |
| December 31, 2020 | -30.19M |
| September 30, 2020 | -33.37M |
| June 30, 2020 | -28.37M |
| March 31, 2020 | -24.08M |
| Date | Value |
|---|---|
| December 31, 2019 | -15.87M |
| September 30, 2019 | -14.07M |
| June 30, 2019 | -13.83M |
| March 31, 2019 | -14.90M |
| December 31, 2018 | -15.67M |
| September 30, 2018 | -14.47M |
| June 30, 2018 | -15.94M |
| March 31, 2018 | -14.67M |
| December 31, 2017 | -12.98M |
| September 30, 2017 | -12.72M |
| June 30, 2017 | -13.83M |
| March 31, 2017 | -13.23M |
| December 31, 2016 | -13.22M |
| September 30, 2016 | -13.83M |
| June 30, 2016 | -10.66M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-34.18M
Minimum
Sep 2022
6.113M
Maximum
Dec 2023
-20.96M
Average
-25.96M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
| Regen BioPharma Inc | -0.3258M |
| Clearday Inc | -4.836M |
| Bioxytran Inc | -0.6641M |
| Shuttle Pharmaceuticals Holdings Inc | -5.581M |
| CEL-SCI Corp | -23.07M |